Finecure’s Regulatory Affairs division drives a global export network across 20+ countries, acting as the technical and regulatory backbone for international partners and accelerating their speed-to-market with comprehensive, meticulously compiled documentation.
The regulatory team monitors evolving pharmacopoeial standards (USP/BP/EP) and navigates high-growth markets across North America (including the United States), Latin America, South East Asia, the CIS, and Africa — supporting rapid product launches and continuous commercial supply. Turnkey in-licensing opportunities are available, backed by ready-to-file dossiers.
Request Dossiers & In-Licensing
Turnkey in-licensing opportunities are available from a dossier pipeline prepared to file. For a partner entering a market with a product already registered elsewhere by Finecure, the documentation exists rather than needing to be built — which is usually the difference between a launch measured in months and one measured in years.
Request Dossiers & In-Licensing